2004N-0133 - Part 11 Public Meeting; June 11, 2004
FDA Comment Number : EC19
Submitter : Mr. Peter Robertson Date & Time: 09/07/2004 07:09:04
Organization : AstraZeneca
International Industry
Category :
Issue Areas/Comments
Please see attached comments in response to the specific questions raised in the request for comments on Part 11 review.

AstraZeneca appreciates this opportunity to contribute to the discussion.